Professor Richard Hindley is a Consultant Urological Surgeon and Clinical Lead for Urology at Hampshire Hospitals. Having qualified in Scotland at the University of Dundee, Richard spent his initial surgical training in Brighton before embarking on 6 years specialist Urology training based in the South Thames training region. This included 2 years at King’s Hospital before passing his final surgical exams and travelling to Brisbane for a laparoscopic urology fellowship in 2003. He was also awarded an MSc in Urology for his research in bladder dysfunction in 1999.
Since then he has spent the last 14 years developing the local service and his interests in minimally invasive treatments for urological conditions.
Richard has introduced cutting edge treatments to Hampshire Hospitals, including Greenlight Laser in 2005 and most recently the Rezum procedure in 2017, for which he was instrumental in the pathway of NICE approval. He is the leading surgeon in the UK for this procedure and has performed over 400 cases. He has very much been at the forefront of treatments for benign and malignant conditions of the prostate. His focus is on reducing the side effects of treatments, including the preservation of sexual function.
He is also a recognised expert in prostate cancer diagnosis and focal treatment using technologies such as HIFU and Cryotherapy. Basingstoke is now one of the leading centres in the UK and receives referrals from across the South of England.
Furthermore, Richard is also a very experienced laparoscopic renal surgeon and is now using the Da Vinci robot for the treatment of kidney conditions.
Richard enjoys teaching and training and has helped to introduce laparoscopy, HIFU, Greenlight laser surgery and Rezum to centres around the UK. He has a large research portfolio and is currently recruiting over 50 patients per year to prostate related clinical trials. He regularly presents at National and International Meetings and was a member of the Medical Research Council’s PROMIS trial committee, which investigated the role of imaging in the assessment of patients with suspected prostate cancer. The results of this work were published in The Lancet in 2017.
He has been recently appointed as a Specialist Adviser to NICE’s Interventional Procedures Programme and in 2018 received the honour of Visiting Professor of Knowledge Exchange for Winchester University in the Health and Wellbeing Research Group.